Please login to the form below
Consulting
This page shows the latest Consulting news and features for those working in and with pharma, biotech and healthcare.
Fishawack Health acquires digital marketing agency closerlook
I believe that the combination of our AI/advanced analytics-enabled omnichannel strategy, creative, and digital media with Fishawack Health’s global consulting, commercial and medical communications capabilities will create a
Latest news
-
bluebird bio aiming to separate business units by year-end
expenses as well as increases in consulting fees associated with the ongoing company split.
-
Indigo Medical joins imc group
With the addition of Indigo, imc group will now offer services for clients across seven core divisions, including medical &scientific content, publications, digital &creative, insights &consulting, patient engagement, meetings &events and
-
Fishawack Health acquires market access and HEOR consultancy PRMA Consulting
Global healthcare communications company Fishawack Health has acquired global market access and health economics outcomes research (HEOR) consultancy PRMA Consulting. ... We’re delighted to welcome PRMA Consulting to our group – our third acquisition
-
Pharma marketers’ blog: How to prioritise, perform and prevail
And now for a different perspective on prioritisation. From my experience in different pharma companies and from my consulting work, the skill of prioritisation is a tough one to master.
-
W2O rebrands as ‘health innovation company’ Real Chemistry
The company's expert service brands include W2O, focused on integrated communications, 21GRAMS, focused on advertising and medical, Discern, focused on value-based care consulting and starpower which has a focus
bluebird bio aiming to separate business units by year-end
Indigo Medical joins imc group
Fishawack Health acquires market access and HEOR consultancy PRMA Consulting
Pharma marketers’ blog: How to prioritise, perform and prevail
W2O rebrands as ‘health innovation company’ Real Chemistry
More from news
Approximately 5 fully matching, plus 317 partially matching documents found.
Latest Intelligence
-
Product launches: making the most of your one shot
Consulting, half of drugs rolled out since 2004 didn’t live up to their sales forecasts.
-
Launch excellence in COVID-19 times
interactions, changing consulting, treatment and procedure levels and increasing NHS cost/resource pressures, to name but a few.
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
Emre Vural(pictured) is an Associate Principal in the Life Sciences Practice at CRA and Kishore Gangangari is a Consulting Associate.
-
Successful product commercialisation: what can we learn from the rare disease setting?
The Boston Consulting Group has projected that the orphan drug market will grow almost 11% annually to approximately $240bn by 2024, nearly double the growth projected for all drugs.
-
Is creativity in quarantine?
Better still, the business consulting giant says that ‘companies that harness creativity and data in tandem have growth rates twice as high as companies that don’t’.
Product launches: making the most of your one shot
Launch excellence in COVID-19 times
Sourcing R&D innovation: why pharma companies need to evolve their business models
Successful product commercialisation: what can we learn from the rare disease setting?
Is creativity in quarantine?
More from intelligence
Approximately 3 fully matching, plus 81 partially matching documents found.
Latest appointments
-
Ashfield Advisory adds Mary-Kate McGarry and Emer Jameson to senior leadership team
McGarry (pictured left) joins with 15 years of experience in management consulting, primarily gained at Ernst &Young and Accenture.
-
McCann Health UK appoints Jonathan Kukathasan as president
McCann Health London and Consulting at McCann Health. ... It’s the perfect time to align our teams across the region, including Consulting at McCann Health, to offer our clients a further integrated version of the expertise they’ve come
-
Deborah Keller appointed as chair of Fishawack Health’s board
Keller’s appointment follows a number of recent acquisitions at Fishawack, including the healthcare marketing and scientific communications agency The Hive Health Group and the global market access consultancy PRMA Consulting.
-
David Eatwell joins Porterhouse Insights
Prior to that, he worked within Consulting at McCann Health, where he led its Quantitative Centre of Excellence.
-
Research Partnership appoints Hannah Osborn to MedTech director role
Osborn (pictured left) has over 13 years’ experience in healthcare research and consulting, with a focus on medical devices over the past seven years.
Ashfield Advisory adds Mary-Kate McGarry and Emer Jameson to senior leadership team
McCann Health UK appoints Jonathan Kukathasan as president
Deborah Keller appointed as chair of Fishawack Health’s board
David Eatwell joins Porterhouse Insights
Research Partnership appoints Hannah Osborn to MedTech director role
More from appointments
Approximately 11 fully matching, plus 129 partially matching documents found.
Latest from PMHub
-
Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack
When combined with Fishawack Health’s existing omnichannel services, which span medical communications, commercial, and consulting capabilities, life science companies will have the opportunity to access and benefit from an unrivaled ... I believe
-
Defacto
De Facto is a full-service agency with an international reach providing specialist communications consulting to the healthcare and life science sectors.Beginning with PR at our heart, and incorporating other
-
MnB Intelligence
MnB Intelligence is a strategy consulting firm providing actionable business intelligence to organizations worldwide.
-
Research Partnership’s MedTech Division appoints two Directors
Chris has over 27 years’ experience in healthcare research and consulting and his peers acknowledge him to be a strategic thinker with a demonstrated ability to leverage primary and secondary market ... Andrew is a seasoned market research professional
-
Redbow Consulting Group
Who we are. redbow consulting group is a specialist healthcare strategy consulting company founded in 2013 by Jonathan Dancer.
Redbow Consulting Group
More from PMHub
Approximately 9 fully matching, plus 251 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
-
Senior Account Manager
-
Salary TBC
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
- Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer
- Court rules on AZ and EU’s COVID-19 vaccine dispute
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- US announces $3bn funding boost for antiviral COVID-19 treatments
- Biogen doses first patient in phase 3 systemic lupus erythematosus study
- Kite partners with Shoreline Biosciences to develop allogeneic cell therapies
- ‘Funny’, ha ha: how neurodiverse comedy can help us understand each other
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- BeiGene’s reveals positive data for Brukinsa in head-to-head Imbruvica trial
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Packer Forbes acquired by Four Communications
- AI is transforming pharma R&D – now it can transform pharma marketing
PMHub
KVA Digital
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- How early-stage clinical research is facilitating the new wave of personalised medicines
- By Jorg Taubel...
- Patient diversity in clinical trials needs to be centre stage
- By Danny Buckland...
- Why empathy in digital patient recruitment is vital
- This is where empathy mapping can be incredibly effective....
